- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05072457
Benefit of Assistive Listening Device for Lateralization
May 17, 2023 updated by: Sonova AG
Benefit of Assistive Listening Device for Lateralization and Spatial Hearing
Speech intelligibility in noise will be evaluated in adults with moderate to moderate-severe sensorineural hearing loss using a Phonak Roger microphone and hearing aid with compatible Phonak Roger receiver.
Target speech will be presented from multiple directions while competing diffuse background noise is presented simultaneously.
Participants will repeat back words and percent correct is calculated.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73120
- Hearts for Hearing
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Experienced hearing aid users, age 18 or older
- Bilateral, symmetric moderate to moderate-severe sensorineural hearing loss
- Good understanding of the English language
- Health outer ear as confirmed by otoscopy
- Informed consent as documented by signature
Exclusion Criteria:
- Contraindications to the medical device noted upon otoscopy
- Known hypersensitivity or allergies to materials of the investigations device or comparator
- Inability to produce reliable test results
- Known psychological problems
- Self reported symptoms of vertigo or dizziness
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental
All participants in the study fit with Phonak Audeo P hearing aids and compatible Phonak Roger receivers.
|
Roger On microphone transmitter which is used with Roger receivers and Audeo P hearing aids
Roger Select microphone transmitter which is used with Roger receivers and Audeo P hearing aids
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Lateralization Hearing Ability
Time Frame: Day 1 of 1 day study
|
Participants indicate which direction (left, center, or right) target speech sentences are coming from while competing noise is also presented via four corner speakers.
A higher number of correct responses indicates better lateralization ability.
This will be done with two Roger microphone systems (Roger On and Roger Select)
|
Day 1 of 1 day study
|
Spatial Hearing Ability
Time Frame: Day 1 of 1 day study
|
Participants repeat sentences presented from the left speaker, while ignoring overlapping competing sentences presented from the right speaker.
A higher percentage of correctly repeated words indicates a better spatial hearing score.
This task will be performed using two Roger microphone systems (Roger On and Roger Select)
|
Day 1 of 1 day study
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 18, 2021
Primary Completion (Actual)
December 13, 2021
Study Completion (Actual)
July 2, 2022
Study Registration Dates
First Submitted
September 28, 2021
First Submitted That Met QC Criteria
September 28, 2021
First Posted (Actual)
October 11, 2021
Study Record Updates
Last Update Posted (Actual)
June 15, 2023
Last Update Submitted That Met QC Criteria
May 17, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SRF-387
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hearing Loss, Sensorineural
-
Oticon MedicalNot yet recruitingSensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound
-
Otologics LLCUnknownMixed Conductive and Sensorineural Hearing Loss, Bilateral
-
CochlearCompletedUnilateral Mixed Conductive and Sensorineural Hearing Loss (Diagnosis) | Sensorineural Hearing Loss, Unilateral With Normal Hearing on the Contralateral SideCanada
-
University College, LondonUnknownSensorineural Hearing Loss | Sensory Hearing Loss | Sensorineural Hearing Loss in Left Ear | Sensorineural Hearing Loss in Right Ear | Sensorineural HearingUnited Kingdom
-
Fundación Pública Andaluza para la gestión de la...RecruitingBilateral Sensorineural Hearing Loss | Unilateral Sensorineural Hearing LossSpain
-
University Hospital, AntwerpCochlearRecruitingHearing Loss, Unilateral | Cochlear Implants | Hearing Loss, Sensorineural, Severe | Hearing Loss, Sensorineural, Bilateral | Hearing Loss, Sensorineural, ProfoundBelgium
-
Auris Medical, Inc.TerminatedHearing Loss, Idiopathic Sudden SensorineuralUnited States, Korea, Republic of, Canada
-
Manchester University NHS Foundation TrustUniversity of ManchesterCompletedCochlear Hearing Loss | Sensorineural Hearing Loss, BilateralUnited Kingdom
-
Cochlear Bone Anchored SolutionsCompletedSingle Sided Sensorineural Deafness | Mixed Hearing Loss, UnilateralDenmark, Spain, United Kingdom, Belgium
-
MED-EL Elektromedizinische Geräte GesmbHCompletedSensorineural Hearing Loss, BilateralFrance
Clinical Trials on Roger On microphone
-
Northwestern UniversityPhonak AG, SwitzerlandCompleted
-
Sonova AGHearts for HearingCompleted
-
Advanced BionicsEnrolling by invitationEar Diseases | Hearing Loss | Hearing Disorders | Otolaryngological DiseaseUnited States
-
Ligue Pulmonaire NeuchâteloiseNot yet recruitingChronic Obstructive Pulmonary Disease | Respiratory DiseaseSwitzerland
-
Sonova AGSonova Canada Inc.Completed
-
Sonova AGCompletedHearing Loss | Sensorineural Hearing LossSwitzerland
-
Sonova AGCompleted
-
University of UtahNational Heart, Lung, and Blood Institute (NHLBI); National Institute of Nursing... and other collaboratorsCompletedNoninvasive Ventilation | Speech IntelligibilityUnited States
-
University College, LondonGN ResoundCompletedAuditory Processing Disorder
-
Goalspal LLCRecruitingParkinson DiseaseUnited States